Search Results - "Bochenek, W"

Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis by Bochenek, W. J., Mack, M. E., Fraga, P. D., Metz, D. C.

“…Summary Background : Effective symptom control is a primary concern of most heartburn suffers. Aim : To compare the safety and efficacy of pantoprazole,…”
Get full text

Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis by Metz, D. C., Bochenek, W. J.

“…Summary Objectives : To compare the safety and efficacy of pantoprazole with ranitidine for the maintenance of endoscopically documented healed (grade 0 or 1)…”
Get full text

Prevention of erosive oesophagitis relapse with pantoprazole by Richter, J. E., Fraga, P., Mack, M., Sabesin, S. M., Bochenek, W.

“…Summary Aim : To compare the safety and efficacy of pantoprazole and ranitidine in maintaining erosive oesophagitis healing. Methods : Gastro‐oesophageal…”
Get full text

Dose‐dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers by Tutuian, R., Katz, P. O., Bochenek, W., Castell, D. O.

“…Background: Proton pump inhibitors have emerged as the most effective class of drugs for the treatment of gastro‐oesophageal reflux. Pantoprazole is a proton…”
Get full text

Comparative efficacy of new investigational agents against Helicobacter pylori by Osato, M. S., Reddy, S. G., Piergies, A. A., Bochenek, W. J., Testa, R. T., Graham, D. Y.

“…Background: Emergence of antibiotic resistant Helicobacter pylori has necessitated the identification of alternate therapies for the treatment of this…”
Get full text

Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active‐controlled, double‐blind study by Kovacs, T. O. G., Wilcox, C. M., Devault, K., Miska, D., Bochenek, W.

“…Summary Background : Pantoprazole is a proton pump inhibitor approved for the treatment of erosive oesophagitis and gastro‐oesophageal reflux disease. Aim : To…”
Get full text

Eradication of Helicobacter pylori by 7-Day Triple-Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double-Blind, Randomized Studies by Bochenek, Wieslaw J., Peters, Suzanne, Fraga, Polly D., Wang, Wenjin, Mack, Michael E., Osato, Michael S., El-Zimaity, Hala M. T., Davis, Kelly D., Graham, David Y.

“…ABSTRACT Aim.  To compare the short‐term (7‐day) safety and efficacy of two triple‐therapy regimens using pantoprazole with those of two dual‐therapy regimens…”
Get full text

Secretin, cholecystokinin and the biliary canalicular secretion in the rat by Romański, K W, Bochenek, W J, Unold, J, Szczepaniak, M

“…An attempt has been made to further assess which fraction of bile can be stimulated by the main gastrointestinal hormones in rats. In the cannulated conscious…”
Get more information

Effect of secretin, pancreozymin OP-CCK, and glucagon on bile flow and bile lipid secretion in rats by Romanski, K W, Bochenek, W J

“…Rats equipped with biliary, duodenal, and vena cava cannulae and supplemented with Na taurocholate received 4 hour infusions of gastrointestinal hormones…”
Get full text

Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial by Richter, Joel E, Bochenek, Wieslaw

“…The aim of this dose-response study was to compare the effectiveness of 10 mg, 20 mg, and 40 mg of pantoprazole with that of placebo tablets in the healing and…”
Get full text

Hydrophobic surfactant effects on aortic cholesterol accumulation and atherosclerosis in hypercholesterolemic rabbits by Rodgers, J B, Slowinska, R, Bochenek, W J

“…Studies were performed in hypercholesterolemic rabbits to determine whether the hydrophobic surfactant, Poloxalene 2930 (Pol), is of benefit under these…”
Get more information

Carbohydrate content of apolipoprotein B‐48 from rat chylomicrons of varying density by Bochenek, Wieslaw J., Weber, Peter, Slowinska, Regina, Tang, Gexin, Rodgers, John B.

“…Monosaccharide composition was determined in apolipoprotein B‐48 (apoB) of chylomicrons of rat mesenteric lymph. Chylomicrons were separated into three…”
Get full text

Hydrophobic surfactant inhibits hypercholesterolemia in pair-fed rabbits on a cholesterol-free, low-fat diet by Rodgers, J B, Tang, G, Bochenek, W J

“…Poloxalene, a hydrophobic surfactant, is known to prevent hypercholesterolemia in animals fed a high-fat, high-cholesterol diet. It has not been demonstrated,…”
Get more information

Poloxalene 2930, a hydrophobic surfactant that prevents atherosclerosis, alters composition of rabbit lipoproteins by Kapuscinska, B, Bochenek, W J, Peng, S K, Rodgers, J B

“…Poloxalene 2930, a hydrophobic surfactant, was incorporated into an atherogenic diet at dose levels, 0.5% and 1% of the diet, and fed to rabbits for 10 weeks…”
Get more information

Alterations of secretory pattern of intestinal lipoproteins by the benzoyl ester derivative of poloxalene surfactant (BEP) by Bochenek, W J, Kapuscinska, B, Slowinska, R, Rodgers, J B

“…Hydrophobic surfactant BEP was administered intraduodenally as part of lipid emulsion to rats with cannulated mesenteric lymphatic duct. The effect on the size…”
Get more information

Absorption and excretion of the hydrophobic surfactant, 14C-poloxalene 2930, in the rat by Rodgers, J B, Friday, S, Bochenek, W J

“…Absorption and excretion of 14C-Poloxalene 2930 (PX), a nonionic hydrophobic surfactant of large molecular weight, were studied using bile fistula rats…”
Get more information

Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger–Ellison syndrome by Lew, Edward A., Pisegna, Joseph R., Starr, Julie A., Soffer, Elaine F., Forsmark, Christopher, Modlin, Irvin M., Walsh, John H., Beg, Mirza, Bochenek, Wieslaw, Metz, David C.

“…Background & Aims: Parenteral control of gastric acid hypersecretion in conditions such as Zollinger–Ellison syndrome (ZES) or idiopathic gastric acid…”
Get full text

Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group by Richter, J E, Bochenek, W

“…The aim of this dose-response study was to compare the effectiveness of 10 mg, 20 mg, and 40 mg of pantoprazole with that of placebo tablets in the healing and…”
Get full text

Postauricular (12 msec latency) responses to acoustic stimuli in patients with peripheral, facial nerve palsy by Bochenek, W, Bochenek, Z

“…The postauricular (12 msec latency) response to a loud click stimulation was investigated in 23 patients with facial nerve palsy. Of these patients 21 had an…”
Get more information

Effect of surfactant poloxalene 2930 on food intake, lipid absorption, and serum cholesterol in rats by Rodgers, J B, Kyriakides, E C, Bochenek, W J

“…Effect of hydrophobic surfactant, poloxalene 2930, on lipid absorption was studied in rats. Under acute conditions with surfactant infused intraduodenally with…”
Get more information